Pembrolizumab With Standard Cytotoxic Chemotherapy in Treatment Naive NSCLC Patients With Asymptomatic Brain Metastases

NCT04967417 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Pemetrexed, Carboplatin, Pembrolizumab
DRUG: Paclitaxel, Carboplatin, Pembrolizumab

Sponsor

Samsung Medical Center